SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-046433
Filing Date
2023-04-18
Accepted
2023-04-18 08:05:55
Documents
7
Period of Report
2023-04-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2312072d1_6k.htm 6-K 12723
2 EXHIBIT 99.1 tm2312072d1_ex99-1.htm EX-99.1 15010
3 EXHIBIT 99.2 tm2312072d1_ex99-2.htm EX-99.2 22584
4 EXHIBIT 99.3 tm2312072d1_ex99-3.htm EX-99.3 39826
5 EXHIBIT 99.4 tm2312072d1_ex99-4.htm EX-99.4 53673
6 GRAPHIC tm2312072d1_logo.jpg GRAPHIC 13183
7 GRAPHIC tm2312072d1_logo2.jpg GRAPHIC 5522
  Complete submission text file 0001104659-23-046433.txt   170920
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 23825538
SIC: 2834 Pharmaceutical Preparations